Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study

Non-alcoholic fatty liver disease (NAFLD) comprises a heterogeneous group of metabolic liver diseases and is characterized by the presence of steatosis in at least 5% of hepatocytes. The aim of our study was to assess the effect of the combination therapy of empagliflozin + metformin vs. metformin m...

Descripción completa

Detalles Bibliográficos
Autores principales: Caturano, Alfredo, Galiero, Raffaele, Loffredo, Giuseppe, Vetrano, Erica, Medicamento, Giulia, Acierno, Carlo, Rinaldi, Luca, Marrone, Aldo, Salvatore, Teresa, Monda, Marcellino, Sardu, Celestino, Marfella, Raffaele, Sasso, Ferdinando Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952909/
https://www.ncbi.nlm.nih.gov/pubmed/36830859
http://dx.doi.org/10.3390/biomedicines11020322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952909/
https://www.ncbi.nlm.nih.gov/pubmed/36830859
http://dx.doi.org/10.3390/biomedicines11020322

Ejemplares similares